Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...
A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...
Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.
GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.
Patients with metabolic dysfunction-associated steotohepatitis (MASH) who are already taking a glucagon-like peptide-1 ...
The search for effective weight loss solutions has led to countless diet trends, fitness regimens, and medical interventions.
Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...